Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol Discontinuation in Alzheimer's Disease
NCT00009217Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 1999
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of haloperidol in psychosis, agitation, sponsored by New York State Psychiatric Institute. Started Jan 1999; status: completed.
02
Drugs
haloperidol
03
Conditions
psychosisagitation
Beyond the preview
Go deeper on NCT00009217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009217.